Estrogen withdrawal results in bone loss, research shows that the Estrogen Receptor has a fundamental roleJuly 25, 2003Professor Lance Lanyon, Principal of The Royal Veterinary College, Karla Lee, Helen Jessop, Rosemary Suswillo, Gul Zaman from the Department of Basic Sciences at The Royal Veterinary College have shown in their research that the Estrogen Receptor has a fundamental role in bone cells by adjusting the bone architecture to match the loads individuals place on them. Their paper is published in the latest edition of Nature. The strain imposed by mechanical loading on bone tissue normally stimulates a response by bone cells that results in an adjustment to bone architecture and enables the bone to withstand reasonable loads. This research centred on why this process should become less effective in some 50 per cent of post-menopausal women who suffered fractures as a result. This research shows why estrogen withdrawal results in bone loss - the number of Estrogen Receptors is reduced by the estrogen levels. When estrogen levels decline (as at menopause) ER levels also decline to the extent that they limit the bone cells' adaptive responses to load bearing thus producing an effective environment of disuse or underuse which permits bone loss. Previous research has concentrated on the effects of estrogen on various processes assuming the Estrogen Receptor is more or less constant. One of the Estrogen Receptor's possible early reproductive functions may be to induce skeletal remodelling to release calcium for egg-laying or embyonic delvelopment. Professor Lanyon says 'the ER is amenable to therapy and there may be a way either to regulate it in bone or to affect its activity. For instance Hormone Replacement Therapy will restore the ER number and thus eliminate the restriction on the loading-related response' For a copy of the article, please contact Virginia Fisher at vfisher@rvc.ac.uk Royal Veterinary College, The |
|||||||||||||||||||||
| Related Estrogen Current Events and Estrogen News Articles Heart and bone damage from low vitamin D tied to declines in sex hormones Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Mayo researchers find robotic repair for vaginal prolapse has significant benefits New Mayo Clinic research has found that robotic surgery for vaginal prolapse dramatically reduces patient hospital stay and recovery time. Estrogen therapy likely must be given soon after menopause to provide stroke protection For estrogen replacement to provide stroke protection, it likely must be given soon after levels drop because of menopause or surgical removal of the ovaries, scientists report in the Journal of Neuroscience. Oral contraceptives may benefit women with asthma New research shows that during natural menstrual cycles, women with asthma who were not taking oral contraceptives (OC) had lower exhaled nitric oxide levels (eNO), a marker of airway inflammation associated with asthma, than women who were taking OC. Study shows hormone replacement therapy decreases mortality in younger postmenopausal woman Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women. Hormone mix could cut breast cancer risk and treat symptoms of menopause The right combination of estrogen and a selective estrogen receptor modulator (SERM), which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk. Breast tenderness during hormone replacement therapy linked to elevated cancer risk Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study. Study finds no relationship between PCR rate and race in women with breast cancer Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete response, at the same rate regardless of race, according to researchers at The University of Texas M. D. Anderson Cancer Center. More Estrogen Current Events and Estrogen News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||